title: Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer.
authors.affiliation: Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW.
authors.forename: Paul
authors.initials: P
authors.lastname: Harnett
authors.forename: Ian H
authors.initials: IH
authors.lastname: Kerridge
authors.forename: Christopher F C
authors.initials: CF
authors.lastname: Jordens
authors.forename: Kim
authors.initials: K
authors.lastname: Hobbs
authors.forename: Catherine
authors.initials: C
authors.lastname: Mason
authors.forename: Bronwen M
authors.initials: BM
authors.lastname: Morrell
mesh_terms: D000223:Adaptation, Psychological; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000523:psychology; D011788:Quality of Life
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen